| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-06 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |